Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 01)
Buspirone Hydrochloride Tablet
Product Images NDC 64980-652
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 64980-652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 02)
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 03)
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 04)
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 05)
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 06)
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 07)
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 08)
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 09)
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 10)
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 11)
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 12)
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 13)
This text contains information about Buspirone Hydrochloride tablets, USP, with 5 mg of Buspirone Hydrochloride per tablet. The usual dosage and storage instructions are provided, along with details for pharmacists to dispense the medication properly. The medication should be kept out of reach of children. It also includes the manufacturer details for Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India, and Rising Pharma Holdings, Inc. in East Brunswick, NJ, USA. The medication guide can be found at the link provided. The issue date of the product is 02/2025. Please refer to the package insert for full prescribing information.*
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 14)
The text provides details about the medication "BusPIRone Hydrochloride Tablets, USP" with a dosage of 7.5 mg per tablet. It includes instructions for pharmacists on dispensing, storage conditions, dosage guidance, and the importance of keeping the medication out of reach of children. The manufacturing information indicates that the tablets are manufactured by Graviti Pharmaceuticals Pvt. Ltd in India for Rising Pharma Holdings, Inc in East Brunswick, NJ. The text also references an online Medication Guide available for further information.*
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 15)
This is a prescription for Buspirone Hydrochloride tablets, USP 10mg. The tablets should be stored at room temperature and dispensed in a light-resistant container. The medication guide should be provided separately to the patient. It is important to keep this and all medicines out of the reach of children. The prescription was issued in February 2025 and the medication is manufactured by Graviti Pharmaceuticals Pvt. Ltd in India for Rising Pharma Holdings, Inc. based in New Jersey, USA. Further information can be accessed via the Medication Guide link provided.*
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 16)
Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 17)
The text contains information about Buspirone Hydrochloride tablets, each containing 30mg of the active ingredient. It provides details on dosage, storage conditions, manufacturer, and contact information. The medication is dispensed with a Medication Guide available online. The tablets should be stored at room temperature and dispensed with patient information leaflet separately. It is manufactured by Graviti Pharmaceuticals in Telangana, India, and distributed by Rising Pharma Holdings in East Brunswick, NJ.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
